MedTrace Logo

Evaluate the Performance of JOURNEY II CR in TKA Populations

NCT04818840 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2025-08-20

Study results available
· View outcomes & findings →

Summary

Background:

The JOURNEY II CR Total Knee System consists of femoral component made from oxidized zirconium (OXINIUM)

Purpose:

Post-market evidence generation for JOURNEY II CR Total Knee System

Objectives:

Evaluate the performance of JOURNEY II CR TKA in APAC populations Evaluate the impact of patella resurfacing on the outcomes of JOURNEY II CR TKA

Research participants / locations:

A total of up to 480 knees' information will be collected in up to 15 sites in India, China mainland, Hong Kong, Singapore, Thailand and Japan There will be up to 240 knees for resurfaced patella group and up to 240 knees for un-resurfaced patella group.

Conditions

  • Arthroplasty
  • Replacement
  • Knee

Interventions

DEVICE

Resurfaced Patella

JOURNEY II CR Total Knee System was used for Total Knee replacement

PROCEDURE

Un-resurfaced Patella

JOURNEY II CR Total Knee System was used for Total Knee replacement

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Principal Investigators

  • Julian Yang · Smith & Nephew, Inc.

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-03
Primary Completion
2024-03-15
Completion
2024-03-15

Countries

  • China
  • India
  • Japan
  • Singapore
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04818840 on ClinicalTrials.gov